Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Jun;21(6):691–699. doi: 10.1111/j.1365-2125.1986.tb05235.x

The effects of diabetes mellitus, exercise, and single doses of biguanides upon lactate metabolism in man.

P Fletcher, M R Hirji, S Kuhn, L Alexander, J C Mucklow
PMCID: PMC1400987  PMID: 3741717

Abstract

The polymorphism of phenformin oxidation has been investigated in 103 non-insulin-dependent (Type II) diabetics. The frequency distribution was clearly bimodal and 14 poor metabolisers were identified. The frequency of the recessive allele (0.369) was not significantly different from that found previously in non-diabetics. Six of the extensive metabolisers of phenformin were matched for age, sex and oxidizer phenotype with non-diabetic controls. All subjects underwent a standard 3-min exercise test, using a bicycle ergometer, after which plasma lactate concentration was monitored for 90 min. There was no significant difference between groups in lactate accumulation or elimination. Ten extensive metabolisers, ten poor metabolisers and seven non-diabetics (matched for age, sex and phenotype with seven of the diabetic extensive metabolisers) were challenged with a fasting oral dose of phenformin (50 mg), after which plasma lactate, and blood pyruvate and glucose concentrations were monitored for 4 h. A further ten diabetics (five extensive and five poor metabolisers of phenformin) received a single dose of metformin (1 g) following an identical protocol. No significant changes were observed in any group.

Full text

PDF
691

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CRAIG J. W., MILLER M., WOODWARD H., Jr, MERIK E. Influence of phenethylbiguanide on lactic, pyruvic and citric acids in diabetic patients. Diabetes. 1960 May-Jun;9:186–193. doi: 10.2337/diab.9.3.186. [DOI] [PubMed] [Google Scholar]
  2. Cesar F. P., Leme C. E., Ohnuma L. Y., Palomino C. R., Wajchenberg B. L. Mechanism of action of phenethylbiguanide (Phenformin) in man IV. Effect of phenethylbiguanide (PBG) on glucose tolerance and lactate dynamics in obese nondiabetic and chemical diabetic subjects. Metabolism. 1980 Mar;29(3):270–278. doi: 10.1016/0026-0495(80)90069-4. [DOI] [PubMed] [Google Scholar]
  3. Doar J. W., Cramp D. G., Maw D. S., Seed M., Wynn V. Blood pyruvate and lactate levels during oral and intravenous glucose tolerance tests in diabetes mellitus. Clin Sci. 1970 Aug;39(2):259–269. doi: 10.1042/cs0390259. [DOI] [PubMed] [Google Scholar]
  4. Doar J. W., Cramp D. G. The effects of obesity and maturity-onset diabetes mellitus on L(+) lactic acid metabolism. Clin Sci. 1970 Aug;39(2):271–279. doi: 10.1042/cs0390271. [DOI] [PubMed] [Google Scholar]
  5. GUETTLER F., PETERSEN F. B., KJELDSEN K. THE INFLUENCE OF PHENFORMIN ON BLOOD LACTIC ACID IN NORMAL AND DIABETIC SUBJECTS DURING EXERCISE. Diabetes. 1963 Sep-Oct;12:420–423. doi: 10.2337/diab.12.5.420. [DOI] [PubMed] [Google Scholar]
  6. Hermann L. S., Nathan E., Ebbesen I. The influence of phenformin on lactate metabolism in diabetic patients in relation to hypoxia and exercise. Acta Med Scand. 1973 Jul-Aug;1-2(1):111–116. doi: 10.1111/j.0954-6820.1973.tb19414.x. [DOI] [PubMed] [Google Scholar]
  7. Nattrass M., Todd P. G., Hinks L., Lloyd B., Alberti K. G. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia. 1977 Apr;13(2):145–152. doi: 10.1007/BF00745143. [DOI] [PubMed] [Google Scholar]
  8. Oates N. S., Shah R. R., Idle J. R., Smith R. L. Genetic polymorphism of phenformin 4-hydroxylation. Clin Pharmacol Ther. 1982 Jul;32(1):81–89. doi: 10.1038/clpt.1982.130. [DOI] [PubMed] [Google Scholar]
  9. Oates N. S., Shah R. R., Idle J. R., Smith R. L. Influence of oxidation polymorphism on phenformin kinetics and dynamics. Clin Pharmacol Ther. 1983 Dec;34(6):827–834. doi: 10.1038/clpt.1983.257. [DOI] [PubMed] [Google Scholar]
  10. Oates N. S., Shah R. R., Idle J. R., Smith R. L. On the urinary disposition of phenformin and 4-hydroxy-phenformin and their rapid simultaneous measurement. J Pharm Pharmacol. 1980 Oct;32(10):731–732. doi: 10.1111/j.2042-7158.1980.tb13056.x. [DOI] [PubMed] [Google Scholar]
  11. Phillips P. J., Thomas D. W., Harding P. E. Biguanides and lactic acidosis. Br Med J. 1977 Jan 22;1(6055):234–234. doi: 10.1136/bmj.1.6055.234-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schäfer G. Interaction of biguanides with mitochondrial and synthetic membranes. The role of phospholipids as natural binding sites. Eur J Biochem. 1974 Jun 1;45(1):57–66. doi: 10.1111/j.1432-1033.1974.tb03529.x. [DOI] [PubMed] [Google Scholar]
  13. Schäfer G. Some new aspects on the interaction of hypoglycemia-producing biguanides with biological membranes. Biochem Pharmacol. 1976 Sep 15;25(18):2015–2024. doi: 10.1016/0006-2952(76)90424-x. [DOI] [PubMed] [Google Scholar]
  14. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol. 1969 Mar;22(2):246–246. doi: 10.1136/jcp.22.2.246-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Varma S. K., Heaney S. J., Whyte W. G., Walker R. S. Hyperlactataemia in phenformin-treated diabetics. Br Med J. 1972 Jan 22;1(5794):205–206. doi: 10.1136/bmj.1.5794.205. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES